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The causative mutations for familial Mediterranean fever (FMF) are located in the MEFV
gene, which encodes pyrin. Pyrin modulates the susceptibility to apoptosis via its PYD
domain, but how the mutated versions of pyrin affect apoptotic processes are poorly
understood. Spontaneous and induced rates of systemic neutrophil apoptosis as well
as the levels of proteins involved in apoptosis were investigated ex vivo in patients
with FMF using flow cytometry and RT-qPCR. The freshly collected neutrophils from the
patients in FMF remission displayed a significantly larger number of cells spontaneously
entering apoptosis compared to control (6.272.14 vs. 1.690.18%). This elevated
ratio was retained after 24 h incubation of neutrophils in the growth medium (32.47.41
vs. 7.651.32%). Correspondingly, the mRNA level for caspase-3 was also significantly
increased under these conditions. In response to the inducing agents, the neutrophils
from FMF patients also displayed significantly elevated apoptotic rates compared to
control. The elevated rates, however, can be largely explained by the higher basal ratio of
apoptotic cells in the former group. Monitoring of several proteins involved in apoptosis
has not revealed any conventional mechanisms contributing to the enhanced apoptotic
rate of neutrophils in FMF. Although the exact molecular mechanisms of accelerated
neutrophil apoptosis in FMF remain unknown, it may provide a protection against
excessive inflammation and tissue damage due to a massive infiltration of neutrophils
in the acute period of the disease.
Keywords: familial Mediterranean fever, autoinflammation, apoptosis, neutrophils, whole blood
Introduction
Familial Mediterranean fever [FMF, MIM249100] is an autoinflammatory syndrome characterized
by the recurrent episodes of fever and polyserositis. The underlying cause of the disease is mutations
in the MEFV gene, which encodes the protein called pyrin or marenostrin (1, 2). The protein is
primarily expressed in neutrophils, eosinophils, and cytokine-activated monocytes (3), and it is
thought it regulates the activation of caspase-1 and IL-1β (4–6). Via the PYD domain, pyrin interacts
with ASC (apoptosis-associated speck-like protein with a caspase recruitment domain), which
overexpression is closely associated with inflammation and apoptosis (7, 8). ASC is a central adaptor
protein of the inflammasome, whichmediates interaction of the pathogen recognition receptors and
caspase 1 (9). Despite the controversies regarding the exact mechanisms by which themutated pyrin
versions cause the episodes of sterile inflammation, it is believed that pyrin influences formation
of yet unknown inflammasome, a multiprotein complex that mediates activation of caspase-1 and
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subsequent secretion of IL-1β. In a number of studies, the NALP3
inflammasome complex has been implicated in the pathogenesis
of FMF (6, 10); whereas in other works, it has been associated with
its own, pyrin inflammasome (11).
The hallmark of FMF is the self-limiting periods of intense
inflammation, which is mainly mediated by a massive influx of
polymorphonuclear neutrophils (PMNs) into the inflamed sites
(12). Remission between the episodes of acute inflammation is
also characterized the enhanced pro-inflammatory activity of cir-
culating PMNs, thus suggesting a subclinical inflammation in
FMF (13). Although a chronic pro-inflammatory state of neu-
trophils could be detrimental to the host, it has been suggested
that, in the past, this FMF feature had provided an increased
resistance to an as yet unidentified infectious agent and thus the
carriers ofMEFV mutations had better survival rates (14, 15). The
state of activated PMNs, however, could be harmful to tissues,
and the timely elimination of them via apoptosis is an important
biological function for the successful resolution of inflammation
and prevention of tissue damage (16). The apoptotic activity of
neutrophils is constitutive (17), and it can be influenced by a
number of extracellular factors such as host-derived cytokines,
extracellular nucleotides, and pathogen-derived ligands (18–20),
which can accelerate or suppress the life span of neutrophils (21).
The intrinsic activation of the apoptotic pathway in neutrophils
may also happen in response to cellular stress and damage, and
it is tightly controlled by the balance of pro- and anti-apoptotic
proteins of the Bcl-2 family (22).
Despite the importance of apoptosis in the down-regulation
and eventual resolution of the inflammatory response, there is
limited information available regarding the apoptotic activity of
neutrophils in FMF, and the results are contradictory. In partic-
ular, some of them suggested the accelerated rate of spontaneous
apoptosis during the acute flares (23), while others reported no
changes in the rate of PMNs apoptosis (24). The main aim of our
work was to investigate whether the rates of spontaneous apopto-
sis of neutrophils in FMF are different compared to the norm. We
also compared the level of apoptosis induction in neutrophils from
the FMF and control cohorts in response to the external signals,
such as tumor necrosis factor alpha (TNFα), lipopolysaccharide
(LPS), adenosine triphosphate (ATP), muramyl dipeptide (MDP),
synthetic bacterial lipopeptide (Pam3CSK4), and colchicine. We
also monitored the expression of proteins involved in apoptosis
such as anti-apoptotic MCL-1, heat shock protein 70 (Hsp70),
tumor suppressor protein p53, and caspase-3 in neutrophils from
the FMF and control subjects.
Materials and Methods
Patients
Two groups of volunteers were recruited for the study. The first
group included 16 FMF patients during the disease remission
(12 males, 4 females; age 14–41 years, mean age 24.2 years). The
clinical diagnosis of FMF was based on Tel-Hashomer criteria
(25). Genetic confirmation for theMEFV mutation carrier status
was performedby theCentre ofMedicalGenetics (Yerevan,Arme-
nia). Determination of the disease stage was based on clinical
and laboratory findings (fever, FMF-related symptoms, such as
abdominal and thoracic pain, arthritis, high levels of C-reactive
protein, white blood cell counts, and erythrocyte sedimentation
rate). The remission phasewas defined as being free of these symp-
toms for at least 2 weeks. Peripheral blood samples from patients
with FMF were obtained during the visits to the Department
of Gastroenterology and Familial Mediterranean Fever, Medical
Centre Armenia (Yerevan, Armenia). All FMF patients in the
study did not receive any colchicine treatment before. The control
group consisted of 11 sex- and age-matched healthy individuals
(7 males, 4 females; age 22–39 years, mean age 27.3 years) with
no personal or family history of FMF. Peripheral blood of healthy
controls was provided by the blood bank of the Viola company
(Yerevan, Armenia). Written informed consents were obtained
from all study participants. The study was approved by the Ethical
Committee of the Institute of Molecular Biology of the NAS RA
(IRB IORG0003427).
Sampling and Whole Blood Cell Culture
The rate of apoptosis and expression of MCL-1, Hsp70, and p53
were determined in neutrophils from the freshly collected venous
blood samples of FMF and control subjects. The blood samples
were collected in sterile EDTA-coated tubes and processed within
2 h after the blood collection. The whole blood samples (100µl)
were incubated at 37°C in the RPMI-1640 medium supplemented
with 10% fetal calf serum, 2mmol/l -glutamine, 1mM sodium
pyruvate, 5mM HEPES, 100 units of penicillin, and 100µg of
streptomycin. The effect of the following agents was tested during
the 3 and 24 h incubations: TNFα and LPS (at final concentra-
tion of 10 ng/ml), ATP-γ-S (100µM/ml), MDP and Pam3CSK4
(2.5µg/ml), and colchicine (2µg/ml). After the incubation, blood
cells were drawn from the culture, washed with PBS, and the con-
taminating erythrocytes were removed by brief hypotonic lysis.
Measurement of PMN Apoptosis
The apoptotic index of neutrophils was quantified by staining
the white blood cells with biotin-conjugated Annexin V (BD
Bioscience). After the incubationwith the saturated concentration
of biotin-conjugated Annexin V, the cell suspension was further
incubated with PE-conjugated Streptavidin (BD Bioscience). The
positively stained apoptotic cells were counted, and the apoptotic
indexwas calculated as the percentage of apoptotic cells within the
total number of cells.
Measurement of Intracellular Protein Expression
The level of intracellular proteins p53 and Hsp70 in neutrophils
was measured in the whole blood cells by immunofluorescent
antibody staining and analyzed by quantitative flow cytome-
try. Briefly, the cell suspension was fixed in the solution with
formaldehyde (final concentration 2%) and stained with the
FITC-conjugated mouse monoclonal [C92F3A-5] anti-human
Hsp70 and PE-conjugated mouse [DO-1] anti-human p53
(Abcam, UK) in the permeabilization solution (0.1%, eBio-
science). The isotype-matched IgG2a (FITC) and IgG1 (PE)
antibodies (eBioscience) were used throughout the experiments
as negative controls for Hsp70 and p53, respectively. The
dual-fluorochrome spectral overlapwas compensated by using the
cells separately stained with the FITC- or PE-labeled antibodies.
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Approximately, 10,000 events were collected per sample. Forward
scatter and side scatter were used to identify the PMN population
and to separate other cells (monocytes and lymphocytes) and
debris. Data were analyzed using the CellQuest software (BD
Biosciences), and the mean fluorescence intensity (MFI) as well
as the percentage of apoptotic cells were used to quantify the
responses to the agents listed above.
The level of intracellular MCL-1 in neutrophils was stained
with mouse monoclonal [8C6D4B1] MCL-1 primary antibody
(Abcam, UK). The secondary antibody treatment was with anti-
mouse IgG biotin (eBioscience), which was followed by staining
with FITC-conjugated Streptavidin (eBioscience, UK).
PMNs Culture
In brief, venous blood (12ml) was collected into the sterile vacu-
tainer tubes containing EDTA (Vacutest Kima s.r.l., Arzergrande,
Italy). Peripheral blood neutrophils were isolated by density cen-
trifugation using Ficoll-Hypaque gradient. Erythrocytes contam-
inating the granulocyte fraction were removed by brief hypotonic
lysis. The purity of granulocytes, as determined by counting the
cytospin preparations stained with May-Grundwald Giemsa, was
consistently >95%. The viability of neutrophils, as assessed by try-
pan blue exclusion, was >95%, immediately after the purification.
The purified neutrophils (1 106 cells/ml) were cultured in
polypropylene tubes in the RPMI medium 1640 supplemented
with 10% fetal calf serum and 2mmol/L of -glutamine in a total
volume of 1ml for 24 h at 37°C. After the growth, neutrophils were
washed from the cultivation media with cold PBS.
RNA Extraction and RT-qPCR
Total RNA isolation, cDNA synthesis and qPCR were performed
as described previously (13). qPCR assay was conducted with
the TaqMan assay primers (CASP3: Hs.PT.47.2840197; Integrated
DNA Technologies) and with in-house developed primers and
probes with the following oligonucleotide sequences: RPL32 (for-
ward) – 50-GAA GTT CCT GGT CCA CAA CG-30, RPL32
(reverse) – 50-GCG ATC TCG GCA CAG TAA G-30, and RPL32
LNA probe #17. The RPL32 gene expression was used for the nor-
malization of mRNA concentration in neutrophils. The human
universal reference RNA (Stratagene, La Jolla, CA, USA) was used
as a calibrator at the concentration of 1.25 ng RNA/reaction in
quadruplicates (26). The relative expression level was calculated
using the second derivative method (Rotor Gene software 6.1.71,
Corbett Research).
Statistical Analysis
Statistical analyses were carried out using the Statsoft Statis-
tica package (http://www.statsoft.com). For continuous vari-
ables, groups were compared using a two-sample t-test or a
Mann–Whitney U test if data were not normally distributed. The
percentage of the apoptotic cells is given as mean SEM. p-values
<0.05 were considered as significant.
Results
Apoptosis Rates in PMN Cells
To evaluate the impact of FMF on the apoptotic processes in
systemic PMNs, we measured the spontaneous rates of apoptosis
in the cells from FMF patients compared to healthy subjects at
0, 3, and 24 h (Figure 1A). Also, the corresponding rates were
estimated for the cells treated by LPS, TNFα, MDP, CSK4, ATP,
and colchicine for 3 and 24 h (Figure 1B).
Spontaneous Apoptotic Rates
The spontaneous apoptotic rates of systemic neutrophils from
FMF patients were found to be significantly higher compared to
the cells from healthy subjects. The basal (0 h) level of apoptotic
PMNs in the whole blood of FMF patients exceeded the corre-
sponding values of the healthy subjects by 3.7-fold (6.27 2.14
and 1.69 0.18%, respectively; p< 0.05) (Figure 1A). No signif-
icant differences in the apoptotic rates of neutrophils from both
sources were detected following a 3 h incubation period. The
incubation resulted in a minor increase of the apoptotic rate in
control PMNs (from 1.69 to 3.72%, p= 0.11), while the opposite
trend, with a slight decrease (from 11.5 to 4.7%, p= 0.27), was
observed for the FMF neutrophils. Following the 24 h incubation,
however, the proportion of apoptotic PMN cells in the blood of
FMF patients wasmore than fourfold higher compared to the con-
trol group (32.4 7.41 and 7.65 1.32%, respectively; p< 0.01)
(Figure 1A).
Induced Apoptotic Rates
The effect of various ligands, which may differentially affect
the rates of apoptosis in systemic neutrophils from the diseased
and healthy subjects, was evaluated with the cells incubated in
the presence of LPS, TNFα, MDP, CSK4, ATP, and colchicine.
About 3 h exposure to LPS caused a small but significant delay
of apoptosis in neutrophils from the healthy subjects (3.72 0.94
and 2.81 1.04% for the non-exposed and LPS-exposed neu-
trophils, respectively; p= 0.05) (Figure 1B). The short exposure
of neutrophils from the healthy subjects to TNFα also resulted
in a delayed apoptosis (3.72 0.94 and 2.9 0.94% for the non-
exposed and TNFα-exposed neutrophils, respectively; p= 0.05)
(Figure 1B). The 3 h exposure of neutrophils from healthy con-
trols to other ligands (MDP, CSK4, ATP, and colchicine) had no
discernible impact on the percentage of apoptotic cells. No signif-
icant differences in the apoptotic rates of neutrophils exposed to
3 h incubation with the ligands were found between the diseased
and healthy subjects (Figure 1B).
A more prolonged 24 h incubation of blood from the healthy
subjects resulted in a significant increase of the apoptotic rate
in neutrophils in response to certain ligands. These were: LPS
(15.76 4.12 and 7.65 1.32%; p< 0.05), TNFα (18.44 3.81
and 7.65 1.32%; p< 0.05), MDP (10.86 1.29 and 7.65
1.32%; p< 0.05), and CSK4 (14.61 1.66 and 7.65 1.32%;
p< 0.05). The incubation with ATP and colchicine had no signif-
icant effect on the rate of apoptosis in this cohort (Figure 1B).
On the contrary, the PMN cells from the FMF patients
were much less responsive to the 24 h incubation with the lig-
ands in terms of the apoptotic rate (Figure 1C). When com-
pared to the control group, however, the apoptotic rates were
significantly elevated in response to all inducers used. Specif-
ically, PMNs from the FMF patients displayed higher apopto-
sis rates compared to the control subjects in response to LPS
(45.75 13.8 vs. 15.76 4.12%; p< 0.05), TNFα (50.17 7.41
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FIGURE 1 | (A) Spontaneous apoptotic rate of neutrophils in the whole
blood of FMF patients (FMF; n= 8) and healthy subjects (Cont; n= 8) in
culture (media): 0 – basal apoptotic rate; 3 h – spontaneous apoptotic rate
of the cells cultured in media (untreated) for 3 h; 24 h – spontaneous
apoptotic rate of the cells cultured in media (untreated) for 24 h. Data are
represented as the % annexin V+ cells (meanSEM). *p<0.05,
**p<0.01 – significant value. (B,C) Effects following inducers: LPS,
TNF-α, MDP, Pam3CSK4 (CSK4), ATP, colchicine (Col) on the apoptotic
rate of circulating neutrophils in the blood of patients with FMF and healthy
subjects (CTL) cultured for 3 (B) and 24 h (C). *p<0.05 vs. untreated cells;
#p<0.05, ##p<0.01 vs. healthy PMNs. Data are represented as the %
annexin-V+ cells (meanSEM).
vs. 18.44 3.81%; p< 0.01, respectively), MDP (29.5 10.21 vs.
10.86 1.29%; p= 0.05), CSK4 (46.77 9.49 vs. 14.61 1.66%;
p< 0.01), ATP (24.38 5.04 vs. 7.25 0.85%; p< 0.01), and
colchicine (39.62 11.86 vs. 8.22 1.41%; p< 0.05). Need to
note, however, that the basal spontaneous rate of apoptosis dur-
ing the 24 h incubation of PMNs from the FMF patients was
already significantly higher compared to the control samples in
the absence of any ligand (Figures 1A,C). Thus, the differences
described above can be largely explained by the high basal sponta-
neous rate of apoptosis in PMNs from the FMF patients compared
to the control subjects.
Caspase-3 mRNA Level
One of the key mediators of apoptosis is caspase-3, and we there-
fore assessed its expression in the freshly isolated neutrophils
as well as in neutrophils cultured in the media by RT-qPCR.
The baseline level of the caspase-3 transcript in neutrophils was
not different between the FMF and control groups. The tran-
script level in the former group, however, tended to be signif-
icantly higher compared to the latter after the 24 h cultivation
of neutrophils only with media (0.160 0.037 vs. 0.052 0.012;
p= 0.05) (Figure 2A).
Baseline and Induced Levels of Hsp70, p53, and
MCL-1 in Neutrophils
The level of proteins involved in regulation of apoptotic events
such as Hsp70, p53, and MCL-1 was assessed in neutrophils from
both cohorts using the flow cytometry technique. The effect of
TNF-α, LPS, and ATP on the level of these proteins was measured
following 3 h incubation with these agents. The levels of all three
proteins in neutrophils from the control subjects were uniform
and were not affected by the exposure to TNFα, LPS, and ATP
(Figures 2B–D). The baseline levels of Hsp70, p53, and MCL-1
were not different between the two investigated groups. How-
ever, a slight increase in Hsp70 and decrease in p53 expression
in neutrophils from the FMF patients tended to be significant.
The MFI corresponding to the Hsp70 level in PMNs from the
FMF patients was increased compared to the control subjects
(422.6 27.7 #MFI vs. 326.9 44.7; p= 0.07) (Figure 2B). On the
contrary, the level of p53 in PMNs was slightly decreased in the
diseased group compared to control (219.4 18.3 vs. 284.4 32.9;
p= 0.08) (Figure 2C).
Cultivation of PMNs from the FMF patients in the media
without the ligand addition for 3 h led to the drastic twofold
decrease in theHsp70 level (422.6 27.7 and 214.5 13.7, respec-
tively; p< 0.001) (Figure 2B). Despite the initial higher level of
Hsp70 in neutrophils from the FMF patients, the identical incu-
bation conditions led to a more pronounced and significant fall
of Hsp70 in the diseased group compared to control (214.5 13.7
and 266.9 11.1, respectively; p< 0.05) (Figure 2B). ATP expo-
sure significantly increased the Hsp70 levels only in the FMF
patient-derived cells (214.5 13.7 and 238.5 15.5, correspond-
ingly; p< 0.05). LPS treatment resulted in a significant decrease
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FIGURE 2 | (A) Scatterplot showing caspase-3mRNA levels in isolated and
cultured (24 h) in RPMI-1640 medium PMNs from FMF patients (FMF; n= 16)
and healthy subjects (Cont; n= 11) as assessed by RT-qPCR. The expression
of caspase-3 was normalized to that of RPL32. Horizontal bars represent the
mean values for each group. (B–D) Effect of the 3 h exposure of neutrophils
from FMF and control to TNFα (10 ng/ml), ATP (100µM), and LPS (10 ng/ml) on
intracellular expression of Hsp70 (B), p53 (C), and MCL-1 (D). CTL – control
medium. Values are the meanSEM of fluorescence intensity. *p<0.05 vs.
untreated cells; #p<0.05 vs. healthy PMNs; #p<0.05, ##p<0.01 vs. healthy
PMNs.
of Hsp70 in FMF samples compared to control (218.7 11.4 and
257.9 10.1, respectively; p< 0.05). In general, despite the higher
initial level of anti-apoptotic Hsp70 in neutrophils from FMF
patients, they undergo accelerated apoptosis under the in vitro
cultivation and ligand exposure conditions.
The level of p53, which controls p53-dependent apoptosis,
was significantly lower in the PMN cells from FMF patients
compared to healthy controls (191.5 12.4 and 314.4 47.1,
respectively; p< 0.05) (Figure 2C). TNFα treatment resulted in a
slight but significant decrease in p53 expression in the FMF neu-
trophils (191.5 12.4 and 180.3 18.2, respectively; p< 0.01).
Decreased p53 levels were observed in FMF neutrophils com-
pared to that of the healthy after the exposure to all induc-
ers studied: TNFα (180.3 18.2 vs. 312.2 38.1; p< 0.01), ATP
(196.8 17.2 vs. 301.9.8 34.6; p< 0.01), and LPS (186.3 15.7
vs. 321.8 37.6; p< 0.01). In general, and similarly to Hsp70,
the level of p53 is suppressed under the in vitro cultivation
and ligand exposure conditions. Thus, it is highly unlikely that
the apoptotic pathway in neutrophils from FMF patients is
p53-dependent.
There were no significant changes in the anti-apoptotic MCL-
1 levels in the neutrophils from the both groups, irrespectively,
whether or not these cells were subjected to the ligand treat-
ment during the ex vivo incubation in the RPMI-1640 media
(Figure 2D).
Discussion
Here, we compared the rate of apoptosis among the peripheral
neutrophils obtained from the FMF patients in remission and
from the healthy control subjects. Our main finding is that the ex
vivo spontaneous apoptotic rate of neutrophils from the former
group is significantly higher compared to control, immediately
after the isolation and after 24 h incubation in RPMI-1640 media.
This observation was confirmed with two types of the 24 h ex vivo
incubation, one using the whole blood samples and another –with
the purified fraction of PMNs. In accordance with this, the level
of mRNA for caspase-3, which is one of the main executioner
caspases, was significantly higher in the PMNs from the FMF
patients compared to control.
The acute inflammatory attacks in FMF are characterized by
a massive influx of neutrophils into the affected sites, but these
are usually self-limiting and do not cause tissue damage. Ear-
lier studies reported the accelerated rate of apoptosis among the
neutrophils during the disease attack, but no significant changes
in the apoptotic rates in the remission period (23). Generally,
shorter incubation times in the cited work may explain the dis-
crepancy between our results. We also detected no difference in
the apoptotic rates when the incubation time was reduced to 3 h.
Need to note here that even during the FMF remission periods,
the peripheral PMNs remain activated (13). This may contribute
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to the subclinical inflammation in remission (27). The prolonged
activation stage of PMNs, however, is not due to the delayed
apoptosis. On the contrary, as we demonstrated here, the PMNs
are characterized by the accelerated apoptosis.
How the mutated version of pyrin may contribute to the
accelerated apoptotic rate of neutrophils? Pyrin possesses several
functions and, depending on the internal and external cues, it
may be involved in the pro- and anti-inflammotary activities as
well as in apoptotic processes. The nature of the pyrin inter-
action with ASC has been investigated in a number of studies
(8, 28, 29). There is a body of evidence for the pro-apoptotic
effects of ASC (8, 28), as well as for the effect of pyrin as a
modulator of theASC-induced apoptotic process (8). Remarkably,
ASC mRNA expression is significantly increased in the MEFV
mutation-positive group compared to the mutation-negative
group (30).
The multifunctional roles of pyrin and ASC, however, make
it difficult to come up with a simple one-factor mechanistic
model. In particular, pyrin can also interact with caspase-1 (4),
suggesting the possibility for modulating yet another apoptotic
pathway leading to the caspase-1-dependent cell death (31). A
recently proposed paradigm has suggested that pyrin may have
yet another function, serving as a pattern recognition receptor in
the pyrin inflammasome (11). In this paradigm, pyrin is a specific
immune sensor for pathogen modification and inactivation of
RhoGTPases. In response to these cues, pyrinmediates the activa-
tion of caspase-1 inflammasome. Because of the broad variety of
MEFV mutations, the protein encoded may have differential spa-
tial conformations. This may result in different protein–protein
interaction dynamic, thus leading to the extremely large varia-
tions in the apoptotic cell ratio in this group compared to the
more tightly distributed range of apoptotic cells in the healthy
neutrophils (Figure 1A).
We proposed earlier that PMNs in FMF are characterized by
a heightened sensitivity toward stress/host-derived ligands (13),
which could be a result of lower threshold concentrations needed
for the activation of NALP3/pyrin inflammasomes. Continuous
activation of the inflammasome in FMF, presumably by even
normal physiological concentrations of ligands, can contribute
to the enhanced ASC apoptotic signaling. Thus, pyrin-mediated
modulation of ASC, which itself possesses a dual role in inflam-
mation and apoptosis, may lead to the pro-inflammatory and pro-
apoptotic pathways, which appear to be not mutually exclusive.
Moreover, the apoptosome and the NLRP3 inflammasome share
common activating factors such as the oxidized mitochondrial
DNA (32). Themain source of the oxidizedmitochondrial DNA is
the intracellular reactive oxygen species (ROS) that are produced
by the activated neutrophils. ROS also participates in the initia-
tion of apoptosis in neutrophils leading to the lysosomal damage
and release of cathepsins, which, in turn, trigger the release of
cytochrome C from mitochondria (33). It has been shown earlier
that the neutrophils in FMF produce high levels of endogenous
ROS (34).
The accelerated apoptosis rate of neutrophils from FMF
patients during the 24 h ex vivo incubation in culture media is
also supported by the elevated level of mRNA for caspase-3.
The elevated mRNA expression of one of the main executioner
caspases is consistent with the mechanism of the altered apoptosis
in FMF neutrophils proposed above. We also demonstrated here
that the FMF neutrophils cultivated in the presence of various
signaling compounds respond differently to them in terms of
the apoptotic rates than the neutrophils from the healthy sub-
jects. PMNs from FMF patients are significantly less responsive
to the external stimuli applied compared to the control cells.
The higher percentage of apoptotic cells seen in the former
group is simply the reflection of the higher spontaneous apop-
totic rate.
It remains unclear, however, what are the endogenous stimuli
that spontaneously trigger the neutrophils harboring the mutated
version of pyrin into the pro-apoptotic pathway. They must be
already present at point 0 conferring a 3.7-fold increase in the
apoptotic rate of these susceptible neutrophils compared to the
normal (Figure 1A). The same proportionally elevated level of
apoptotic PMN cells in this group remains also after 24 h incuba-
tion in the growth media, suggesting that this is a self-sustainable
process driven mainly by the internal factors. The nature of
these endogenous factors remains elusive and further research is
necessary to identify them.
We also investigated a possible involvement of several key
apoptotic pathways in the accelerated apoptosis of PMNs with
the mutated version of pyrin. We report, for the first time, that
this apoptotic process does not involve the pathways associ-
ated with p53, Hsp70, and MCL-1. There was no correlation
between the expression of these proteins and the accelerated
apoptosis rate characteristic for the PMNs carrying the mutated
pyrins.
Conclusion
At the first glance, the accelerated apoptosis of neutrophils in
FMF seems rather contradictory to the conventional view that the
cells in the pre-activated state have the extended lifespan. There
is a body of evidence that the in vitro induction of apoptosis in
non-infectious inflammation models enhances the resolution of
inflammation (35). We hypothesize here that the MEFV muta-
tions have been selected not only for conferring the heightened
sensitivity that allows triggering the immediate and non-specific
innate inflammatory responses against the invading pathogens.
The multi-functional pyrin, which is also involved in the apop-
totic processes, may have been a good source for the selec-
tion of pleiotropic mutations that are simultaneously involved
in the rapid onset of inflammation in response to infection as
well as in rapid resolution of inflammation. Thus, the acceler-
ated intrinsic apoptotic rates of neutrophils in FMF may have
a protective effect in preventing tissue damage due to excessive
inflammation.
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